Indication
Cholinergic Urticaria
4 clinical trials
5 products
1 drug
Product
LEO 152020Clinical trial
Phase 2a Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic UrticariaStatus: Completed, Estimated PCD: 2022-07-08
Product
LigelizumabClinical trial
A Two-part Exploratory Study Combining a Pilot Study in Healthy Subjects and Chronic Spontaneous Urticaria Patients (Part 1) and a Randomized, Subject, Investigator and Sponsor-blinded, Placebo Controlled, Study (Part 2) to Assess the MechAniSm of acTion of ligElizumab (QGE031) in Patients With Chronic uRticaria (MASTER)Status: Terminated, Estimated PCD: 2022-07-19
Product
PlaceboClinical trial
An Open Label, Phase 1 Single Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CDX-0159 as Add on Therapy in Patients With Cold Contact Urticaria, Symptomatic Dermographism and Cholinergic UrticariaStatus: Completed, Estimated PCD: 2022-12-16
Product
CDX-0159Clinical trial
A Randomized, Double-blind, Placebo-controlled, Proof of Concept, Multicenter, 16-week Treatment Study With a 16 Week Follow-up Period to Assess the Efficacy and Safety of Dupilumab (Anti-IL4Ra) in Adult Patients With Cholinergic Urticaria Despite H1-antihistamine TreatmentStatus: Completed, Estimated PCD: 2023-02-28
Product
DupilumabDrug
Varlilumab